Chang Bing Show Chwan Memorial Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2014
NCT02238587
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Pei-Yuan Lee, MD | Show Chwan Memorial Hospital | Show Chwan Memorial Hospital, Changhua, Taiwan

Active Ingredients

Drugs in Other Trials (4)

calcium (1 trial)

essential oils (1 trial)

ganoderma lucidum spore (1 trial)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 4